Document is current

Article History

Received: 21 February 2025

Accepted: 4 July 2025

First Online: 6 August 2025

Declarations

:

: Vivian Y. Shi is a stockholder of Learn Health and has served as an advisory board member or investigator and/or received research funding from Pfizer Inc, Sanofi-Genzyme, Regeneron, AbbVie, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa Pharmaceuticals, UCB, Altus Lab, MYOR, Polyfin, GpSkin, and Skin Actives Scientific. Brian Esparza and Erman Güler are employees and shareholders of Pfizer Inc. Jonathan I. Silverberg served as an investigator for Celgene, Eli Lilly and Company, F. Hoffmann-La Roche, Menlo Therapeutics, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; as a consultant for Pfizer Inc., AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Menlo Therapeutics, Novartis, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; and as a speaker for Regeneron Pharmaceuticals and Sanofi Genzyme.

: Study documents and procedures for the studies discussed in this podcast were approved by the appropriate institutional review boards/ethics committees at each study site. The trials discussed in this podcast were conducted in accordance with the ethical principles from the Declaration of Helsinki, International Ethical Guidelines for Biomedical Research Involving Human Subjects from the Council for International Organizations of Medical Sciences, and International Council for Harmonisation Good Clinical Practice Guidelines. Informed consent was obtained from all individual participants included in both trials discussed in this podcast.